The Clinical Trials Abundance blog

Cure all diseases

Few people know how much medicine has progressed in their lifetimes. Fewer know how much faster it could be progressing.

Published on The Works in Progress Newsletter • 13 hrs ago

July 2026

Market shaping and trial design belong together

Two birds, one trial

Jul 14 • Witold Więcek

20

9

4

June 2026

Why were Covid vaccine trials so fast?

The timeline to develop coronavirus vaccines blew many predictions out of the water.

Jun 26 • Saloni Dattani

91

4

28

The new HHS trial reforms are more ambitious than they look

A Deeper Dive into Operation TrialBlazer

Jun 23 • Adam Kroetsch

12

4

The US moves to reclaim the therapeutic pipeline

A welcome move from the FDA and HHS

Jun 22 • Ruxandra Teslo

13

5

1

Manufacturing requirements are killing cell and gene therapy

Some of the most promising drugs are bottlenecked by a "boring" but incredibly important problem

Jun 10 • Ruxandra Teslo and Amol Punjabi

27

1

2

Clinical trial innovations don't scale. Here's why, and how to fix it.

A Policy Agenda for Efficient, Abundant Clinical Trials

Published on Policy and Practice • Jun 8

Who Owns the FDA's Thinking?

A law firm says that FDA’s rejection letters reveal too much. That may be exactly why the public needs them.

Published on Policy and Practice • Jun 1

May 2026

FDA’s Real-Time Clinical Trials Pilot Could Transform Drug Development

The approach is promising. The challenge is scaling it up.

May 11 • Adam Kroetsch

31

6

8

April 2026

How to speed up clinical trials

Why is drug testing so slow and inefficient, and how can we fix it?

Published on The Works in Progress Newsletter • Apr 22

56:13

Clinical Trials Were Not Always This Complicated

How trials got so bureaucratic, and how some leaders pushed back

Apr 8 • Adam Kroetsch

47

4

11

March 2026

FDA Bayesian trials guidance is good, but will we make a good use of it?

How can regulators apply their own guidance?

Mar 30 • Witold Więcek

18

7